473 related articles for article (PubMed ID: 23923370)
21. Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents.
Cardoso AS; Gonzaga NC; Medeiros CC; Carvalho DF
J Pediatr (Rio J); 2013; 89(4):412-8. PubMed ID: 23791233
[TBL] [Abstract][Full Text] [Related]
22. Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men.
Park SH; Kim BI; Kim SH; Kim HJ; Park DI; Cho YK; Sung IK; Sohn CI; Kim H; Keum DK; Kim HD; Park JH; Kang JH; Jeon WK
J Am Coll Nutr; 2007 Aug; 26(4):321-6. PubMed ID: 17906183
[TBL] [Abstract][Full Text] [Related]
23. Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals.
Cordeiro A; Pereira SE; Saboya CJ; Ramalho A
Biomed Res Int; 2015; 2015():839253. PubMed ID: 26120587
[TBL] [Abstract][Full Text] [Related]
24. Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors.
Thiagarajan S; Shrinuvasan S; Arun Babu T
Indian J Gastroenterol; 2022 Feb; 41(1):63-68. PubMed ID: 35064452
[TBL] [Abstract][Full Text] [Related]
25. Fatty pancreas in relation to insulin resistance and metabolic syndrome in children with obesity.
Elhady M; Elazab AAAM; Bahagat KA; Abdallah NA; Ibrahim GE
J Pediatr Endocrinol Metab; 2019 Jan; 32(1):19-26. PubMed ID: 30530906
[TBL] [Abstract][Full Text] [Related]
26. Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver.
Sung KC; Lee MY; Kim YH; Huh JH; Kim JY; Wild SH; Byrne CD
Atherosclerosis; 2018 Aug; 275():50-57. PubMed ID: 29860108
[TBL] [Abstract][Full Text] [Related]
27. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.
Shao C; Ye J; Li F; Feng S; Wang W; Zhong B
Dig Liver Dis; 2019 Oct; 51(10):1392-1399. PubMed ID: 30928418
[TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
[TBL] [Abstract][Full Text] [Related]
29. Study and Comparison of Metabolic Profile of Lean and Obese Subjects with Non Alcoholic Fatty Liver Disease.
Shah P; Rathi P; Mandot A; Pal A; Ahire D
J Assoc Physicians India; 2020 Aug; 68(8):51-54. PubMed ID: 32738842
[TBL] [Abstract][Full Text] [Related]
30. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
[TBL] [Abstract][Full Text] [Related]
31. [Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation].
Andreozzi P; Viscogliosi G; Colella F; Subic M; Cipriani E; Marigliano B; Verrusio W; Servello A; Ettorre E; Marigliano V
Recenti Prog Med; 2012 Dec; 103(12):570-4. PubMed ID: 23258240
[TBL] [Abstract][Full Text] [Related]
32. The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults.
Ju DY; Choe YG; Cho YK; Shin DS; Yoo SH; Yim SH; Lee JY; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI
Clin Mol Hepatol; 2013 Jun; 19(2):140-7. PubMed ID: 23837138
[TBL] [Abstract][Full Text] [Related]
33. Metabolic consequences of childhood obesity--a preliminary report.
de Silva KS; Wickramasinghe VP; Gooneratne IN
Ceylon Med J; 2006 Sep; 51(3):105-9. PubMed ID: 17315588
[TBL] [Abstract][Full Text] [Related]
34. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
35. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
Oh SY; Cho YK; Kang MS; Yoo TW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
Metabolism; 2006 Dec; 55(12):1604-9. PubMed ID: 17142131
[TBL] [Abstract][Full Text] [Related]
36. THE CORRELATION OF NECK CIRCUMFERENCE AND INSULIN RESISTANCE IN NAFLD PATIENTS.
Boemeke L; Raimundo FV; Bopp M; Leonhardt LR; Fernandes SA; Marroni CA
Arq Gastroenterol; 2019; 56(1):28-33. PubMed ID: 31141077
[TBL] [Abstract][Full Text] [Related]
37. Association between non-alcoholic fatty liver disease and liver function/injury markers with metabolic syndrome components in class III obese individuals.
Chaves GV; Souza DS; Pereira SE; Saboya CJ; Peres WA
Rev Assoc Med Bras (1992); 2012; 58(3):288-93. PubMed ID: 22735219
[TBL] [Abstract][Full Text] [Related]
38. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.
Sookoian S; Pirola CJ
Aliment Pharmacol Ther; 2017 Jul; 46(2):85-95. PubMed ID: 28464369
[TBL] [Abstract][Full Text] [Related]
39. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.
Hossain IA; Rahman Shah MM; Rahman MK; Ali L
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965
[TBL] [Abstract][Full Text] [Related]
40. Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents.
Jain V; Jana M; Upadhyay B; Ahmad N; Jain O; Upadhyay AD; Ramakrishnan L; Vikram NK
Indian J Med Res; 2018 Sep; 148(3):291-301. PubMed ID: 30425219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
